Loading...
XNYS
ASH
Market cap3.24bUSD
Oct 07, Last price  
70.67USD
1D
-0.42%
1Q
8.72%
Jan 2017
-35.34%
Name

Ashland Inc

Chart & performance

D1W1MN
XNYS:ASH chart
P/E
—
P/S
1.77
EPS
—
Div yield, %
2.33%
Shrs. gr., 5y
-5.49%
Rev. gr., 5y
-1.98%
Revenues
1.82b
-13.68%
7,233,000,0007,785,000,0008,381,000,0008,106,000,0005,741,000,0006,502,000,0006,472,000,0006,091,000,0006,121,000,0003,420,000,0003,019,000,0002,309,000,0002,589,000,0002,148,000,0002,016,000,0002,111,000,0002,391,000,0002,191,000,0002,113,000,0001,824,000,000
Net income
-845m
L
407,000,000230,000,000167,000,00071,000,000141,000,000414,000,00026,000,000683,000,000233,000,000309,000,000-29,000,0001,000,000114,000,000505,000,000-508,000,000220,000,000927,000,000178,000,000169,000,000-845,000,000
CFO
94m
-77.13%
345,000,000195,000,000470,000,0001,025,000,000507,000,000245,000,000354,000,000733,000,000643,000,000333,000,000678,000,000383,000,000297,000,000241,000,000203,000,000560,000,000-213,000,000243,000,000411,000,00094,000,000
Dividend
Sep 01, 20260.42 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.

Related entities

Subsidiaries (14)
ASHLAND INDUSTRIES EUROPE GMBH
ASHLAND SPECIALTIES IRELAND LIMITED
ASHLAND SPECIALTIES UK LIMITED
INTERNATIONAL SPECIALTY PRODUCTS (INDIA) PRIVATE LIMITED
ASHLAND CANADA HOLDINGS B.V.
ASHLAND INDIA PRIVATE LIMITED
ASHLAND INDUSTRIES DEUTSCHLAND GMBH
ASHLAND INDUSTRIES FRANCE
ASHLAND INDUSTRIES NEDERLAND B.V.
ASHLAND INGREDIENTS POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
ASHLAND SERVICES B.V.
ASHLAND SPECIALTIES FRANCE
ASHLAND SPECIALTIES SVERIGE AB
INEOS COMPOSITES HISPANIA SL

Key people

Chairman of the Board, Chief Executive Officer · since 2019
Eileen Drury
Chief Human Resource Officer, Senior Vice President · since 2021
Alessandra Assis
Senior Vice President, General Manager - Life Sciences and Intermediates · since 2024
Dago Caceres
Senior Vice President, General Manager - Specialty Additives · since 2024
Wayne Muil
Senior Vice President - Operations · since 2025
John Willis
Chief Financial Officer, Senior Vice President · since 2013
Osama Musa
Senior Vice President, Chief Technology Officer · since 2018
William Whitaker
Interim Chief Financial Officer, Vice President - Finance, Director - Investor Relations · since 2025
James Minicucci
Senior Vice President, General Manager - Personal Care · since 2024
Robin Lampkin
Senior Vice President, General Counsel, Secretary · since 2023
Independent Director · since 2022
Sanat Chattopadhyay
Independent Director · since 2023
Independent Director · since 2022
Ashish Kulkarni
Independent Director · since 2024
Independent Director · since 2017
Independent Director · since 2018
Scott Tozier
Independent Director · since 2024
IPO date
Mar 17, 1980
Employees
3,900
Domiciled in
US
Incorporated in
US
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
8145 BLAZER DRIVE
WILMINGTON, DE 19808
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT